Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy+Abiraterone/Prednisone and Androgen Deprivation Therapy+Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer

Purpose: This study aimed to compare the short-term outcomes and safety profiles of androgen-deprivation therapy (ADT)+abiraterone/prednisone with those of ADT+docetaxel in patients with de novo metastatic hormone-sensitive prostate cancer (mHSPC). Materials and Methods: A web-based database syst...

Descripció completa

Dades bibliogràfiques

Autors principals:	Dong Jin Park, Tae Gyun Kwon, Jae Young Park, Jae Young Joung, Hong Koo Ha, Seong Soo Jeon, Sung-Hoo Hong, Sungchan Park, Seung Hwan Lee, Jin Seon Cho, Sung-Woo Park, Se Yun Kwon, Jung Ki Jo, Hong Seok Park, Sang-Cheol Lee, Dong Deuk Kwon, Sun Il Kim, Sang Hyun Park, Soodong Kim, Chang Wook Jeong, Cheol Kwak, Seock Hwan Choi
Format:	Artigo
Idioma:	Inglês
Publicat:	Korean Society for Sexual Medicine and Andrology 2024-07-01
Col·lecció:	The World Journal of Men's Health
Matèries:	abiraterone acetate adverse effects docetaxel prostatic neoplasms treatment outcome
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!